Impact Biomedical files preliminary merger proxy
Impact Biomedical filed a DEFM14A form. The filing date is shown as October 27, 20.
Related stories
Norwegian Cruise Line shares rise after raising full-year earnings outlook
Shares rose about 13% premarket after Norwegian Cruise Line raised its full-year earnings outlook, citing stronger-than-expected last-minute bookings and higher onboard spending.
M impact | EQUITY | Oct 29, 2026, 12:23 PM UTC
Federal Signal Reports Q3 Results
Federal Signal reported its third-quarter results.
M impact | EQUITY | Oct 29, 2026, 12:15 PM UTC
Mastercard Publishes Third-Quarter 2026 Earnings Release
Mastercard published its third-quarter 2026 earnings release.
M impact | EQUITY | Oct 29, 2026, 12:12 PM UTC
Bethel Automotive Safety Systems Q3 net profit rises 5.17% year over year
M impact | EQUITY | Oct 29, 2026, 12:12 PM UTC
US Equity Futures Edge Lower Before the Bell
US equity futures were edging lower before the bell Thursday.
M impact | EQUITY | Oct 29, 2026, 12:12 PM UTC
MilliporeSigma Opens €300 Million Bioprocessing Center in Daejeon
MilliporeSigma opened a €300 million Asia-Pacific bioprocessing center in Daejeon.
M impact | EQUITY | Oct 29, 2026, 12:12 PM UTC